


To invest in a portfolio of North American securities. The current policy is to invest for capital growth without any distribution target.
| Name | % Net Assets | 
|---|---|
| Exxon Mobil | 3.9% | 
| Microsoft | 3.3% | 
| Merck & Co | 3.1% | 
| Cisco Systems | 3.0% | 
| Abbott Laboratories | 2.5% | 
| Procter & Gamble | 2.4% | 
| Merck & Co | 2.2% | 
| Hewlett Packard | 2.1% | 
| Abbott Laboratories | 1.9% | 
| Chevron | 1.9% | 
| Key | % Net Assets | 
|---|---|
| 3.9% | |
| 3.3% | |
| 3.1% | |
| 3.0% | |
| 86.7% | 
| Date | 09-Sep-2022 | 
|---|---|
| NAV | 305.70p | 
| Currency | GBP | 
| Change | 1.10p | 
| % | 0.36% | 
| YTD change | 305.70p | 
| YTD % | n/a | 
| Fund Inception | 01/07/1995 | 
|---|---|
| Fund Manager | Tom Luddy / Susan Bao | 
| TER | 1.68 (31-Jan-2013) | 
| Minimum Investment | |
|---|---|
| Initial | £1000 | 
| Additional | £100 | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 4.25% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research